Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/β-catenin signaling pathway in human rectal carcinomas

Cancer Research

Volumn 66, Issue 1, 2006, Pages 267-282

  Grade, Marian ^a,b   Ghadimi, B Michael ^a   Varma, Sudhir ^b   Simon, Richard ^b   Wangsa, Danny ^b   Barenboim Stapleton, Linda ^b   Liersch, Torsten ^a   Becker, Heinz ^a   Ried, Thomas ^b   Difilippantonio, Michael J ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CASEIN KINASE IALPHA; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOOXYGENASE 2; DECORIN; DNA; EPHRIN B2; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 4; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN BCL 2; PROTEIN MSH2; PROTEIN P53; RNA; SOMATOMEDIN B; SUMO PROTEIN; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UBIQUITIN; UNINDEXED DRUG; VASCULOTROPIN; WNT PROTEIN;

ANEUPLOIDY; ARTICLE; CARCINOGENESIS; CHROMOSOMAL LOCALIZATION; CHROMOSOME 13Q; CHROMOSOME 18Q; CHROMOSOME 20P; CHROMOSOME 20Q; CHROMOSOME 7P; CHROMOSOME 8Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RECTUM BIOPSY; RECTUM CARCINOMA; RECTUM MUCOSA; TRANSCRIPTION REGULATION;

ADENOCARCINOMA; ANEUPLOIDY; BETA CATENIN; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; MULTIGENE FAMILY; NUCLEIC ACID HYBRIDIZATION; RECTAL NEOPLASMS; SIGNAL TRANSDUCTION; WNT2 PROTEIN;

EID: 31544438541     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2533     Document Type: Article

References (35)

1. Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353:391-9.
2. Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O, Heim S. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer 1995;12: 97-109.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Ried T, Knutzen R, Steinbeck R, et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15: 234-45.
5. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg 2002;89:845-60.
6. Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 1999;25:195-204.
7. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
8. Ghadimi BM, Grade M, Difilippantonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005;23:1826-38.
9. Simon R, Peng A. BRBArrayTools; 2003.
10. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003;19: 2448-55.
11. Dudoit S, Fridlyand J. A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol 2002;3:RESEARCH0036.
12. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275: 1784-7.
13. Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol 2000;190:412-6.
14. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002;123:1109-19.
15. Ghadimi BM, Grade M, Liersch T, et al. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer. Clin Cancer Res 2003;9:1808-14.
16. Knosel T, Schluns K, Stein U, et al. Chromosomal alterations during lymphatic and liver metastasis formation of colorectal cancer. Neoplasia 2004; 6:23-8.
17. Upender MB, Habermann JK, McShane LM, et al. Chromosome transfer induced aneuploidy results in complex deregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res 2004;64: 6941-9.
18. Monni O, Barlund M, Mousses S, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci U S A 2001;98:5711-6.
19. Virtaneva K, Wright FA, Tanner SM, et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 2001; 98:1124-9.
20. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 2002;99: 12963-8.
21. Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 2002;62:6240-5.
22. Wolf M, Mousses S, Hautaniemi S, et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia 2004;6:240-7.
23. Leuenroth S, Riethdorf S, Erbersdobler A. et al. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation. BJU Int 2005;96:553-7.
24. Wang QA, Gao H, Wang YH, Chen YL. The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer. Jpn J Surg 1991;21:253-61.
25. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;434:907-13.
26. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.
27. Ha PK, Califano JA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 2003;14:363-9.
28. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
29. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25.
30. Cianchi F, Cortesini C, Bechi P. et al. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology 2001;121:1339-47.
31. Araki Y, Okamura S, Hussain SP, et al. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 2003;63:728-34.
32. Wang D, Mann JR, DuBois RN. WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle 2004;3:1512-5.
33. Behrens J, Lustig B. The Wnt connection to tumorigenesis. Int J Dev Biol 2004;48:477-87.
34. Farago M, Dominguez I, Landesman-Bollag E, et al. Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Res 2005;65:5792-801.
35. Jabbour L, Welter JF, Kollar J, Hering TM. Sequence, gene structure, and expression pattern of CTNNBL1, a minor-class intron-containing gene-evidence for a role in apoptosis. Genomics 2003;81: 292-303.